Back to Rankings

NUVL

NuvalentB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-16
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
NUVL vs peer average
64/100
NUVL vs. peer average (B vs. C)
Grade spread
A 2 · B 2 · C 1 · D 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

RGC is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $9.76B

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerRGCRegencell Bioscience
NUVL
Nuvalent
RGC
Regencell Bioscience
Grade
B
D
Momentum
69
5
Value
41
41
Sentiment
-
100
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs RGC

NUVL / RGC
Grade Position
In line
NUVL vs. peer average (B vs. C)
64/100
Momentum
69
NUVL
Value
41
NUVL
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NUVL
1
RGC
Regencell Bioscience Holdings Ltd Common
D
40/100
+2
2
KRYS
Krystal Biotech Inc Common
B
80/100
Even
3
SMMT
Summit Therapeutics Inc Common
F
20/100
+3
4
CRL
Charles River Laboratories International Inc Common
A
100/100
-1
5
ARWR
Arrowhead Pharmaceuticals Inc Common
A
100/100
-1
RGC is the first peer returned for this comparison set.